Causal association between complement system FHR-5, CTRP9, and breast carcinoma in situ: a Mendelian randomization study

CONCLUSIONS: This MR study marks the initial identification of a direct link between FHR-5 and CTRP9 and the susceptibility to breast carcinoma in situ. Delving into the roles of immunomodulatory molecules and immune responses within the tumor microenvironment holds considerable importance for the management of breast carcinoma in situ.PMID:38567599 | DOI:10.26355/eurrev_202403_35743

Source: European Review for Medical and Pharmacological Sciences - April 3, 2024 Category: Drugs & Pharmacology Authors: Y-L Peng H Li P Sun H-D Zhang D Li H-B Wang L Zhang Source Type: research